Toward a cure

The scientists at Medtronic Diabetes are working toward introducing the ultimate breakthrough in diabetes management: the artificial pancreas.

The MiniMed Paradigm® REAL-Time Insulin Pump and Continuous Glucose Monitoring System marks the latest and most significant milestone in achieving that vision.
Scientific breakthroughs and superior support services - these are the advantages you expect from the industry leader.

Medtronic Diabetes pioneered Insulin Pump Therapy and Continuous Glucose Monitoring, and has led the development of diabetes management solutions for more that 20 years.

Since then, hundreds of thousands of people worldwide have used insulin pump therapy solutions from Medtronic Diabetes. And for more than 150,000 people worldwide, our continuous glucose monitoring system have provided valuable insights into glycaemic control. We're comitted to building on our expertise to help deliver the best health and quality of life for people with diabetes all over the world.